Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells

Oncology Reports

Volumn 27, Issue 1, 2012, Pages 114-120

  Hong, Su Hyun ^a   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

Author keywords

Apoptosis; Bufalin; G2 M; T24 cells

Indexed keywords

BUFALIN; CASPASE 3; CASPASE 8; CASPASE 9; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER INHIBITION; CELL ACTIVATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BUFANOLIDES; CARCINOMA, TRANSITIONAL CELL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

EID: 84855288196     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1451     Document Type: Article

References (28)

1. Wu X, Ros MM, Gu J and Kiemeney L: Epidemiology and genetic susceptibility to bladder cancer. BJU Int 102: 1207-1215, 2008.
2. Bartsch G, Mitra AP and Cote RJ: Expression profiling for bladder cancer: strategies to uncover prognostic factors. Expert Rev Anticancer Ther 10: 1945-1954, 2010.
3. Supit W, Mochtar CA, Sugiono M and Umbas R: Survival of patients with transitional cell carcinoma of the urinary bladder in Indonesia: a single institution review. Asian Pac J Cancer Prev 12: 549-553, 2011.
4. Evans VG: Multiple pathways to apoptosis. Cell Biol Int 17: 461-476, 1993.
5. Fulda S and Debatin KM: Apoptosis signaling in tumor therapy. Ann NY Acad Sci 1028: 150-156, 2004. (Pubitemid 40361819)
6. Earnshaw WC, Martins LM and Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 6: 383-424, 1999. (Pubitemid 29449198)
7. Stennicke HR and Salvesen GS: Properties of the caspases. Biochim Biophys Acta 1387: 17-31, 1998. (Pubitemid 28529204)
8. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
9. Adams JM and Cory S: Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26: 61-66, 2001. (Pubitemid 32124712)
10. Jiang C, Yang YF and Cheng SH: Fas ligand gene therapy for vascular intimal hyperplasia. Curr Gene Ther 4: 33-39, 2004. (Pubitemid 38854944)
11. Yeh JY, Huang WJ, Kan SF and Wang PS: Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate 54: 112-124, 2003. (Pubitemid 36120327)
12. Watabe M, Kawazoe N, Masuda Y, Nakajo S and Nakaya K: Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cells. Cancer Res 57: 3097-3100, 1997. (Pubitemid 27351717)
13. Yu CH, Kan SF, Pu HF, Jea Chien E and Wang PS: Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Sci 99: 2467-2476, 2008.
14. Jiang Y, Zhang Y, Luan J, Duan H, Zhang F, Yagasaki K and Zhang G: Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. Cytotechnology 62: 573-583, 2010.
15. Li D, Qu X, Hou K, Zhang Y, Dong Q, Teng Y, Zhang J and Liu Y: PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Anticancer Drugs 20: 59-64, 2009.
16. Takai N, Ueda T, Nishida M, Nasu K and Narahara H: Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med 21: 637-643, 2008.
17. Kawazoe N, Watabe M, Masuda Y, Nakajo S and Nakaya K: Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene 18: 2413-2421, 1999. (Pubitemid 29206154)
18. Ryu DS, Baek GO, Kim EY, Kim KH and Lee DS: Effects of polysaccharides derived from Orostachys japonicus on induction of cell cycle arrest and apoptotic cell death in human colon cancer cells. BMB Rep 43: 750-755, 2010.
19. Choi JH, Choi AY, Yoon H, Choe W, Yoon KS, Ha J, Yeo EJ and Kang I: Baicalein protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis through inhibition of reactive oxygen species production and CHOP induction. Exp Mol Med 42: 811-822, 2010.
20. Paul S, Mandal SK, Bhattacharyya SS, Boujedaini N and Khuda-Bukhsh AR: In vitro and in vivo studies demonstrate anticancer property of root extract of Polygala senega. J Acupunct Meridian Stud 3: 188-196, 2010.
21. Cho SY, Lee JH, Bae HD, Jeong EM, Jang GY, Kim CW, Shin DM, Jeon JH and Kim IG: Transglutaminase 2 inhibits apoptosis induced by calcium-overload through down-regulation of Bax. Exp Mol Med 42: 639-650, 2010.
22. Masuda Y, Kawazoe N, Nakajo S, Yoshida T, Kuroiwa Y and Nakaya K: Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res 19: 549-556, 1995.
23. Yi CH and Yuan J: The Jekyll and Hyde functions of caspases. Dev Cell 16: 21-34, 2009.
24. Parsons MJ and Green DR: Mitochondria in cell death. Essays Biochem 47: 99-114, 2010.
25. Yin XM: Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res 10: 161-167, 2000.
26. Eckelman BP, Salvesen GS and Scott FL: Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7: 988-994, 2006. (Pubitemid 44480512)
27. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347, 1994. (Pubitemid 24300618)
28. Hunter AM, LaCasse EC and Korneluk RG: The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12: 1543-1568, 2007. (Pubitemid 47106887)